Pharma Provider Vetter Accelerates Switch to Renewable Energy
Vetter aims to reduce its absolute greenhouse gas emissions by 58.8% by 2034 (base year 2021). A key lever for this is the continuous switch to renewable energies.
Vetter
Pharma Service Provider Vetter Establishes New Site in Chicago
Vetter broke ground for the start of construction of its new clinical site in Des Plaines, Illinois, US on June 26.
The Evolution of the CDMO Industry
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine. CHEManager asked executives and industry experts from a broad range of CDMOs to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Expert Statement: Thomas Otto and Peter Soelkner, Vetter
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
